GSK vs. RXRX
Compare and contrast key facts about GlaxoSmithKline plc (GSK) and Recursion Pharmaceuticals, Inc. (RXRX).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: GSK or RXRX.
Correlation
The correlation between GSK and RXRX is 0.40, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
GSK vs. RXRX - Performance Comparison
Loading data...
Key characteristics
GSK:
26.89%
RXRX:
118.47%
GSK:
-55.21%
RXRX:
-12.62%
GSK:
-17.44%
RXRX:
-8.94%
Fundamentals
GSK:
$74.41B
RXRX:
$1.76B
GSK:
$2.02
RXRX:
-$1.80
GSK:
2.45
RXRX:
29.44
GSK:
3.95
RXRX:
1.88
GSK:
$31.53B
RXRX:
$59.76M
GSK:
$22.56B
RXRX:
-$46.00K
GSK:
$8.24B
RXRX:
-$534.16M
Returns By Period
GSK
9.47%
5.72%
3.18%
-15.44%
1.27%
2.63%
RXRX
N/A
N/A
N/A
N/A
N/A
N/A
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
GSK vs. RXRX — Risk-Adjusted Performance Rank
GSK
RXRX
GSK vs. RXRX - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for GlaxoSmithKline plc (GSK) and Recursion Pharmaceuticals, Inc. (RXRX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
GSK vs. RXRX - Dividend Comparison
GSK's dividend yield for the trailing twelve months is around 4.24%, while RXRX has not paid dividends to shareholders.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
GSK GlaxoSmithKline plc | 4.24% | 4.60% | 3.75% | 4.78% | 4.92% | 5.49% | 4.28% | 5.55% | 5.72% | 7.06% | 5.96% | 6.09% |
RXRX Recursion Pharmaceuticals, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Drawdowns
GSK vs. RXRX - Drawdown Comparison
The maximum GSK drawdown since its inception was -55.21%, which is greater than RXRX's maximum drawdown of -12.62%. Use the drawdown chart below to compare losses from any high point for GSK and RXRX. For additional features, visit the drawdowns tool.
Loading data...
Volatility
GSK vs. RXRX - Volatility Comparison
Loading data...
Financials
GSK vs. RXRX - Financials Comparison
This section allows you to compare key financial metrics between GlaxoSmithKline plc and Recursion Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities